free hit counters
Gilead Pharmaceuticals – QNotes

U.S. sues over PrEP

Gilead Said to Be Infringing on Patents

According to a press release by the Department of Justice, Gilead Sciences, Inc. has infringed upon four U.S. patents in connection with the pharmaceutical company’s Truvada and Descovy, which are marketed to prevent HIV as part of the PrEP regimen.